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Abstract
Background: The care itinerary for cancer involves difficulties that occur in several different areas, whether in the
diagnostic procedures, in surgery, or in adjuvant treatment. The aim of this work was to obtain a valid instrument
measuring satisfaction among patients with breast cancer and exploring their care itinerary overall.
Methods: Development phase: Patient focus groups were implemented in two French regions in order to identify areas
of satisfaction in relation to the different phases of care provision in breast cancer. On the basis of the literature and the
themes and wordings derived from the focus groups, the patients identified several areas of satisfaction, which they found
to be partially covered in an American satisfaction measure that has been validated in the French general population (the
Consumer Satisfaction Survey in its French version, CSS-VF, 39 items). The patient focus groups suggested adaptation of
certain dimensions of this instrument to the potential care providers (37 items) and produced 45 new items in six areas.
Validation phase: Using a large sample of patients (cohort of 820 women with invasive non-metastatic breast cancer)
approached one month after treatment, this phase selected items that were comprehensible (non-response rate < 10%),
non-redundant (r < 0.80) and reproducible (test-retest conducted on a sub-sample of 166 patients). The dimensions
were identified by factor analysis on the selected items. Divergent and discriminant validity were assessed (relationships
with quality of life questionnaire, comparisons between extreme groups).
Results: Results were in favour of not inserting additional broken-down items into the CSS-VF and retaining 21 new
items. The factor analysis found the initial structure of the CSS-VF (39 items in 9 dimensions) and the 21 new items divide
up into four dimensions (listening abilities and information provided by doctors, organisation and follow-up of medical
care provision, psychological support, material environment). No redundancy was observed between new items and
CSS-VF items. Internal consistency was high. Divergent and discriminant validity were satisfactory.
Published: 16 July 2007
BMC Cancer 2007, 7:129 doi:10.1186/1471-2407-7-129
Received: 14 March 2007
Accepted: 16 July 2007
This article is available from: http://www.biomedcentral.com/1471-2407/7/129
© 2007 Defossez et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
BMC Cancer 2007, 7:129 http://www.biomedcentral.com/1471-2407/7/129
Page 2 of 11
(page number not for citation purposes)
Conclusion: Adding four new dimensions to the CSS-VF yielded a valid 60-item instrument for assessment of care
provided in breast cancer. These promising results now require further investigations of its responsiveness and its
robustness in other linguistic, cultural and healthcare settings.
Background
Breast cancer is the most frequent cancer among women,
with a little over one million new cases per year world-
wide [1]. Over recent years, the way the disease has been
catered for has changed (screening, diagnosis, prognostic
markers, new surgical techniques, oral treatment, etc). As
a result, prognosis has improved, and patients have a
more regular follow-up by physicians. Alongside this, the
assessment of patient satisfaction has gained ground in
the literature on cancer. This can be explained by the
importance given to patient preferences in medical deci-
sions, and also by the need to measure the results of
health strategies [2,3]. Thus today measuring satisfaction
among patients with non-metastatic breast cancer over the
complete the care itinerary is an essential step in improv-
ing the way the pathology is catered for [3-6].
Satisfaction is a concept that is at once theoretical, multi-
dimensional, and subjective. This concept, which cannot
be measured by direct observation of the care provided,
involves the identification of expectations, needs, percep-
tions, past experiences, opinions and attitudes of patients
[4,7,8]. Several authors have thus considered that the
assessment of satisfaction required an operational formal-
isation of the concept into dimensions with their constit-
uent items making up questionnaires [7], and hence this
rapidly entailed the need to assess the psychometric prop-
erties of such instruments [9].
The majority of these instruments were developed in the
USA or the United Kingdom, and socio-cultural differ-
ences or differences in the health systems restricted their
use in assessment of care itineraries in other countries. In
addition, many of these questionnaires measure satisfac-
tion in hospitalised patients, while others focus on a par-
ticular moment in the care itinerary, such as the
consultation [10-17]. Finally, some questionnaires do not
possess the required psychometric properties [18,19].
The care itinerary for breast cancer involves difficulties
that occur in several different areas, whether in the radio-
logical and histological diagnostic procedures, in surgery,
or in complementary treatment. Pluri-disciplinarity is
essential in the therapeutic decision, and this entails coor-
dination of care interventions throughout treatment, as
well as between the different phases of treatment, and
subsequent to treatment. The range of expertise required
leads to time lapses, and complicates the organisation of
care. This applies to all the actors in the care itinerary, and
the time required to reach collegiate decisions can have a
negative effect on patients. Patients expect care to be
instated promptly, and to be accompanied by clear infor-
mation and psychological support.
To our knowledge, no satisfaction questionnaire explores
patient opinion in the different phases of treatment for
breast cancer, while several areas of satisfaction have quite
specific links with these particular care itineraries.
The aim of the study was therefore to develop a question-
naire measuring satisfaction with the care itinerary as a
whole among patients with non-metastatic breast cancer
subsequent to initial treatment. In view of the repeated
developments of new satisfaction questionnaires, and the
time required to construct and validate them [20,21], we
decided to start from an existing validated satisfaction
questionnaire, the Consumer Satisfaction Survey in its
French version [22,23].
Methods
This study was conducted in two French administrative
regions (Aquitaine and Poitou-Charentes) representing 7
to 8% of the national population of France. This study is
integrated into a general project of evaluative research on
the performance of health networks, entitled REPERES
(Recherche Evaluative sur la Performance des Réseaux de
Santé).
This article reports on the two phases of the development
and validation of this questionnaire (Figure 1):
1. The first phase (qualitative method) was conducted to
generate items and identify domains, using a literature
review and focus groups involving breast cancer patients;
2. The second phase (quantitative method) was the first
steps of a validation process designed to identify the best
set of items using psychometric and statistics methods,
and to analyse the association or correlation with other
external indicators and assess the known-group validity of
the new tool.
Development of the questionnaire (qualitative method)
Two focus groups were organised successively, involving
fifteen patients with cancer for each focus group. The
patients were selected to ensure diversity within the focus
group, both for clinical and socio-demographic character-
istics and for care itinerary [see Additional file 1]. The
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Simplified development and validation process of the REPERES-60 questionnaireFigure 1
Simplified development and validation process of the REPERES-60 questionnaire.
DEVELOPMENT PHASE 
(QUALITATIVE METHOD) 
Conceptual framework of satisfaction 
Literature review Focus Groups 
Experts 
Preliminary version 
Application in a sample of 
breast cancer patients 
VALIDATION PHASE 
(QUANTITATIVE METHOD)
Analysis of internal validity 
Factorial structure of the questionnaire 
Measurement properties of the final questionnaire 
1. Test-retest reliability (dimensions) 
2. Item-scale correlations 
3. Inter-scale correlations 
4. Internal scale consistency 
Item selection 
1. Distribution of items 
2. Redundancy 
3. Test-retest reliability (items) 
Analysis of external validity 
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mean age of patients was 62 years (range 40 to 78), and
six were retired. All women were some time from their ini-
tial treatment, and were either in remission or in relapse
for some cases.
The first group interviews aimed to stimulate participants
to put their personal experiences into words, and to
explore their perception of quality in the care process [24].
The interviews, recorded with the agreement of the partic-
ipants, were intended to collect the wordings used by non-
medical individuals to talk about certain medical notions.
A review of the literature had been conducted to find
seven published questionnaires
[10,11,13,14,22,23,25,26], which enabled the drafting of
a list of satisfaction dimensions which was presented to
the focus group patients. The main domains covered in
the questionnaires reviewed were fairly classic: human
relationships, technical quality of care, accessibility and
convenience, economic aspects, efficiency of care, conti-
nuity of care, material environment and availability of
doctors [7,19,27]. The patients in the focus group succes-
sively discussed the different phases in care and treatment
of breast cancer.
A list of elements for item development (themes and
wordings) derived from the verbatim transcribed from the
first focus groups was developed by the REPERES work
group (sociologists who analysed content).
On the basis of this material, the patients in the second
focus group identified several areas of satisfaction, which
they found to be covered in a questionnaire developed by
Davies & Ware [22] and which has been culturally
adapted and validated in French (CSS-VF) [23].
The second focus group made the choice of using the 9
generic dimensions of the CSS-VF as the basis of their
work. It is true that certain validated satisfaction question-
naires for use among cancer patients such as the EORTC
InPatsat-32 cover some of these dimensions [17], but they
are restricted to the hospitalisation period of the patients'
care itineraries. In addition, the CSS-VF had the advantage
of exploring satisfaction with General Pratitionner (GP)
and specialist care separately: this was indeed used by the
focus group to adapt certain dimensions to the different
health care actors involved in care of breast cancer, adding
37 items. Thus the items concerning the GP were com-
pleted by two items for the gynaecologist and the radiolo-
gist, and the items concerning the specialist were
subdivided into two items, for the surgeon and the oncol-
ogist. This new structure made it possible to distinguish
between primary care, provided routinely for diagnosis
and follow-p by the GP, the gynaecologist and the radiol-
ogist, and secondary care providing treatment of the can-
cer and hence implicating the surgeon and the oncologist.
However several issues in the list derived from the verba-
tim were not covered in the CSS-VF, and they were dis-
cussed and worded as items by the patients, with
methodological support from a sociologist. The patients
in the focus groups put particular emphasis on three main
themes:
- Psychological support, required in the course of the dif-
ferent phases of treatment: in screening procedures or at
the time of the clinical identification of a tumour, when
"sudden psychological pressure sets in", while waiting for
results which are "a big source of anxiety", and at the time
when patients leave the medical environment and return
to work or everyday life, where they gain "awareness" of
the illness, a time when there is a "very great feeling of iso-
lation", whether medical, psychological geographical or
family;
- Listening abilities of doctors and the information they
provide: the importance for patients of someone who will
"listen", who will enable a "person-to person relation-
ship"; the importance of being "informed and accompa-
nied right up to the moment when the consequence of
surgery and the scars are confronted", of being able to
"talk about treatment and its side effects", of being able "
to talk about breast reconstruction surgery early on" and
about "what information to give the close circle of family
or friends";
- The organisation of follow-up after treatment: patients
emphasise " the length and the succession of treatment
phases which is more difficult to cope with than the treat-
ment itself", the need to "have a part in the choice of treat-
ment and mode of care", the importance of feeling that
"staff work as a team ", and that "communication between
the GP and the specialist works well".
The quality of the material environment in which cancer
is cared for and treated was also discussed in the focus
groups, and although the theme is present in the litera-
ture, the aspect of the confidentiality afforded by premises
is not in fact explored. The themes of efficiency of care and
access to medical information were developed independ-
ently by the REPERES working team, in response to the
fact that the issues of access to medical files was an ongo-
ing debate at the time (cancer plan) and also to the proce-
dures for evaluation of efficiency of care that were being
set up.
Three new items were drafted to complete the existing
dimension on insurance cover and 42 new items were
drafted to fall into five areas of satisfaction: 1) listening
abilities and information provided by the doctors; 2)
organisation and follow-up of medical care provision; 3)
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psycho-social support; 4) outcomes of care; 5) and mate-
rial environment.
The format of the response choices was ordinal, in line
with that used for the CSS-VF, and the best suited to the
positive response trends often observed in satisfaction sur-
veys [7,28].
The test version of the full questionnaire, administered in
the form of a self-assessment, comprised a total of 121
items: 45 new items and 76 derived from the original CSS-
VF. This version of the questionnaire was then tested with
a population of breast cancer patients to assess under-
standing and exhaustiveness of the items, and this led to
some minor alterations to the questionnaire.
Validation of the questionnaire (quantitative method)
Sample and data collection
A cohort survey was conducted from October 2003 in
public and private cancer centres. The patients included in
the cohort complied with the following criteria: 1) a first
diagnosis of invasive non-metastatic breast cancer in the
course of 2003; 2) at least two contacts for cancer with one
of the health professionals in one of the two regions
between diagnosis and the first year of follow-up; 3)
signed informed consent.
The satisfaction questionnaires were sent at three
moments in the care itinerary [29]: one month after the
end of the initial treatment for the study of the psycho-
metric properties of the instrument (this involved the
whole cohort, n = 975); then a year later, and again a week
after that to study reproducibility of items (this involved a
sub-group representative of the cohort obtained by ran-
dom selection, n = 172). The reproducibility study
entailed questioning patients at a stable period in the
course of their disease, and no psychometric study was
performed at one year.
The logistics of data collection were ensured by a team
specifically dedicated the project, and involved recall pro-
cedures at each stage in the study. Telephone support was
established to provide patients with explanations or com-
plementary information on the aims, design and expected
results of the study. The process of patient inclusion as a
whole had been previously approved by the consultative
committee on the processing of information in medical
research of CNIL (French national commission on indi-
vidual privacy).
Responses provided to the questionnaires were captured
using the Data Base Management System 4D Server, and
data were analysed using the SAS programme, version 8.2.
(Windows). A verification procedure was implemented
via independent duplicate data capture to check the whole
data set.
Finally questionnaires that presented more than half the
responses missing were removed from the statistical anal-
ysis.
Analysis of internal validity
Item selection
The selection of items was based mainly on clinical crite-
ria and priorities expressed by patients in the focus
groups. The internal validity of the 121 items was studied
by successively examining the distribution of items, any
redundancy, and their reproducibility over time.
Distribution of items
The distribution of each item was studied to see whether
the full range of response choices was used, in order to
detect items that were not sufficiently informative because
the variability of response was insufficient: floor and ceil-
ing effects. An item was removed if one of the response
choices received more than 50% of the responses pro-
vided [30]. The proportion of missing data was calculated
for each item, and this enabled assessment of how well
understood or how relevant the questions were. A per-
centage of missing data on an item under 10% was con-
sidered acceptable.
Redundancy
Items that were strongly correlated, thus likely to be pro-
viding the same information, were looked for. Redun-
dancy between two questions was suspected if the Pearson
correlation coefficient was over 0.80 in the inter-item cor-
relation matrix [31,32].
Test-retest reliability
The reproducibility of the measure was studied item by
item, examining the agreement between measures at the
time of the two re-administrations of the questionnaire.
As the response format was ordinal, agreement was
explored using a weighted kappa coefficient (Fleiss-Cohen
weighting) taking into account the degree of disagreement
[33]. A kappa coefficient over 0.70 was considered to indi-
cate good reproducibility, it was considered moderate
when values were between 0.50 and 0.70, and insufficient
below 0.50.
The selection of items took other factors into account: 1)
the proportion of non-response: if higher than 10% a
problem of acceptability was likely for the item, without
systematic exclusion at this stage; 2) the number of items
considered sufficient to account for a given dimension: if
at least half the items of a dimension were completed for
the calculation of the score, the choice was made to keep
BMC Cancer 2007, 7:129 http://www.biomedcentral.com/1471-2407/7/129
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the item, so as to retain the information in the particular
dimension.
Factorial structure of the questionnaire
The factorial structure was studied using Principal Com-
ponent Analysis (PCA). The number of factors retained
was determined from eigenvalues greater than or equal to
1 [9]. Factor analysis with rotation enabled identification
of the dimensions in the questionnaire, and showed that
the items selected measured domains that were identical
to those hypothesised at the outset. Rotation was applied
to transform the original principal components produced,
to ease interpretation. This method searches for a linear
combination of the original measurements aiming to
maximize the variance of the components loadings. A Var-
imax rotation (orthogonal) was preferred at a Promax
rotation (oblique) if low correlations were observed
between factors [34]. An item was attributed to a single
factor if it loaded 0.45 or more on a single factor.
Properties of the final instrument: reproducibility, item-scale, and 
inter-scale correlation analyses, scale consistency
The score of each dimension was calculated from the sum
of items, standardised so as to obtain a score between 0
(low satisfaction) and 100 (high satisfaction), according
to the methodology proposed by Davies and Ware [22].
The score was computed if at least 50% of the items in the
dimension were completed. Descriptive statistics were
produced for each of the dimensions (mean, standard
deviation, percentiles, saturation and asymmetry coeffi-
cient).
Reproducibility was studied for the different dimensions
using the intra-class correlation coefficient, calculated
from a 2-factor variance analysis in a random effect model
[35]. An intra-class correlation coefficient over 0.70 was
considered to indicate good reproducibility.
The analysis of item-score correlations looked for correla-
tions greater than 0.40 between items and their own
dimension. The correlation coefficients should be higher
between the item and the dimension to which it belongs
(calculating the score without the item under considera-
tion) than between that item and the other dimensions.
An analysis of the inter-score correlation matrix was con-
ducted to ascertain independence of dimensions for cor-
relation coefficients below 0.70. The Cronbach alpha
coefficient was calculated to assess internal consistency of
each dimension. A coefficient over 0.80 was considered
satisfactory [32]. Floor and ceiling effects for each dimen-
sion were calculated according to the percentage of sub-
jects presenting respectively the maximum and minimum
scores in the dimension considered.
Analysis of external validity
In a first approach, divergent validity was checked by
assessing the relationship between the REPERES-60 scales
and the EORTC QLQ-C30 scales and single items (Euro-
pean Organization for Research and Treatment of Cancer
Quality-of-Life questionnaire) [36]. Health Related Qual-
ity Of Life (HRQOL) summarizes dimensions of the qual-
ity of life which reflect the negative functional
repercussions (on the physical activity, the psychological
state, the social relations) of its disease and its treatment,
such as the patient perceives them [37]. Thus these two
measures are intended to explore two distinct concepts
and their scales and items should not show marked corre-
lation (Pearson's r < 0.40).
In the second approach, the ability of the questionnaire to
discriminate between extreme groups was assessed by
comparing patient groups that were expected to differ
strongly in terms of satisfaction scores. A lower satisfac-
tion level was expected for younger patients (cut-off at the
sample median age of 58), patients with higher education
(versus primary and secondary education), those who had
experienced problems of communication at the time of
the announcement of the diagnosis, and patients who
reported a poor health status (score less than five on the
QLQ-C30 item: "How would you rate your overall health
during the past week ?", scored from very poor to excel-
lent) [38-40]. Discriminant validity was investigated
using non-parametric tests (Wilcoxon test) [41]. We could
estimated, because of none references are existing on this
topic, that a five point difference score between extremes
groups are representing a significant discrimination.
Results
Sample characteristics
Among the 975 patients included, 850 (87%) returned
the initial questionnaire within a median time lapse of 18
days. For the study of reproducibility of items, 172 out of
182 (95%) returned the two questionnaires one year after
the first completion and again a week after this dispatch.
The proportion of exploitable questionnaires, which pre-
sented less than half the responses missing, was over 95%
(820/850 and 166/172). Average patient age was 58.0
years (SD 12.4), the majority were living with a partner or
spouse (55%) and 44% were working (Table 1).
Internal validity
Item selection [see Additional file 2]
Distribution of items
Just one item from the original CSS-VF (Q7) had a high
rate of non-response. The replicated (broken-down) CSS-
VF items relating to the gynaecologist and the radiologist
did not generate adequate response. There was one phe-
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nomenon of saturation of response choices on one item
of the global satisfaction domain (Q71).
Two of the three items generated to complete the health
insurance cover dimension concerned less than one
patient in three. The removal of items Q78-Q79 also led
to removal of item Q77.
Among the 42 new items, 10 out of the 13 that registered
at least 20% non-response were removed from the analy-
sis at this stage. Two items relating specifically to mastec-
tomy or to a particular treatment (Q86 and Q105) were
however maintained on account of the importance given
to them in the focus group. It was also thought necessary
to maintain the third situation-specific item (Q94) in
order to explore the care itinerary as a whole, including all
aspects of care provision.
Nine new items of the 15 for which the percentage of
missing data ranged from 10 to 20% were maintained as
far as the factor analysis. This strategy made it possible to
have a sufficient and fairly homogeneous number of
items for each dimension.
Redundancy
High correlations were found for replicated items in the
primary care dimensions (the breakdown into GP, gynae-
cologist and radiologist), and also for the replicated items
in the secondary care dimensions (for the surgeon and the
oncologist). At this stage these results were in favour of
not inserting these additional broken-down items into the
CSS-VF, but rather of maintaining the original items. In
the subsequent analyses, the broken-down item scores
were averaged, retaining solely the distinction between
primary and secondary care (Q1 to Q63).
Ten of the 42 new items were redundant, but only the
item on information given to understand the treatment
(Q80) was removed. The other items were retained to ena-
ble the measure to give an account of certain specific
sequences in the patients' care itineraries: the time lapses
before receiving treatment (chemotherapy, radiotherapy,
surgery: r = 0.80–0.82), the quality of consultation
premises and respect for privacy in consultations (hospi-
talisation versus consultation: r = 0.87).
No redundancy was evidenced between items in the CSS-
VF and the new items (r ≤ 0.68).
At the end of this stage, 64 items remained out of the 121
items (39 items derived from the CSS-VF and 25 new
items).
Table 1: Sociodemographical characteristics of breast cancer patients who completed satisfaction questionnaires (less than 50% 
missing data)
One month after initial treatment N = 820 One year later and a week after N = 166
Age years (mean ± SD) 58.0 ± 12.4 58.9 ± 12.3
Regional distribution
Aquitaine area 506 (61.7%) 98 (59.0%)
Poitou-Charentes area 314 (38.3%) 68 (41.0%)
Living with spouse or partner
Yes 452 (55.1%) 102 (61.5%)
No 368 (44.9%) 64 (38.5%)
Educational level MD = 18 MD = 3
Primary 190 (23.8%) 46 (28.2%)
Lower secondary 88 (11.0%) 18 (11.0%)
Upper secondary 313 (39.2%) 66 (40.5%)
Higher education 125 (15.7%) 23 (14.1%)
None 82 (10.3%) 10 (6.2%)
Professional status MD = 14 MD = 4
Working 352 (43.7%) 69 (42.6%)
Retired 329 (40.8%) 62 (38.3%)
Homemaker 81 (10.0%) 24 (14.8%)
Job-seeker 29 (3.6%) 4 (2.5%)
Other 15 (1.9%) 3 (1.9%)
N = Sample size
MD = Missing Data
BMC Cancer 2007, 7:129 http://www.biomedcentral.com/1471-2407/7/129
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Test-retest reliability
Reproducibility was satisfactory for ten of the 13 (Q64 to
Q76) remaining CSS-VF items (weighted kappa ≥ 0.70 for
4 items and between 0.60 and 0.69 for 6 others) and for
22 of the 25 new items (weighted kappa ≥ 0.70 for 11
items and between 0.60 and 0.69 for 11 others). For the
six remaining items, the coefficient ranged from 0.55 to
0.59, except for one item in the global satisfaction domain
of the original CSS-VF (Q69, kappa = 0.44). No item was
excluded on the grounds of its kappa coefficient.
Factorial structure [see Additional file 3]
The 64 items retained were entered into principal-compo-
nents factor analysis with varimax rotation and a twelve-
factor PCA solution was retained for 60 items. Four items
were not further considered in the subsequent PCA
because of absence of loading on any common factor
(Q93 to Q96). The factorial structure remained identical
with or without them. The first twelve factors explained
45% of the total variance. The dimension "competence"
and the dimension "communication skills" for specialists
deliberately dissociated in the validation of the French
CSS [23] are found here on a single factor (6 items).
The other dimensions of satisfaction were: "access to pri-
mary care" (7 items), "access to secondary care" (3 items),
"competence and communication skills of primary care
doctors", "choice among different doctors" (4 items),
"human qualities shown by doctors" (4 items), "global
satisfaction" (4 items), "cover for medical expenses" (5
items), "listening abilities and information provided by
the doctor" (7 items), "organisation and follow-up of
medical care provision" (5 items), "psychosocial support"
(5 items) and "material environment" (4 items).
All items had a good loading on their own factor. Only
five items had a loading on a secondary component (I5,
I20- I22, I54).
Properties of the final instrument: reproducibility, item-scale and 
inter-scale correlation analyses, scale consistency [see Additional file 
4]
The reproducibility was very satisfactory for eleven out of
thirteen dimensions. The dimensions "access to second-
ary care" and "competence of doctors in secondary care"
had intra-class correlation coefficients of 0.62 and 0.66
respectively.
Correlation coefficients between items and their hypothe-
sised scale were all greater than 0.4. One item out of the
60 (the possibility of obtaining medical information or
advice by telephone from the GP and/or the gynaecolo-
gist) loaded high on its own scale and also on another
scale. One high inter-scale correlation was observed
between listening abilities and provision of information
by doctors and psychosocial support (r = 0.73). Internal
consistency was very high (all Cronbach alpha coefficients≥ 0.82, except for the global satisfaction score at 0.74).
External validity [see Additional file 5]
None of the thirteen sub-scales were strongly correlated
with the QLQ-C30. The strongest observed correlation
was between the QLQ-C30 global quality of life scale and
the global satisfaction scale (r = 0.29).
A lower satisfaction level was systematically noted for
younger patients, those with higher education, those hav-
ing experienced problems of communication in the
announcement of the diagnosis and those who reported
poor health status. All the sub-scales were able to discrim-
inate between patients in terms of age categories, except
for the sub-scales competence of secondary care doctors
and organisation and follow-up of medical care provi-
sion. Differences in satisfaction scores were not significant
in relation to educational status in five sub-scales: access
to primary care, competence of secondary care doctors,
cover for medical expenses, organisation and follow-up of
medical care provision and psychological support.
Only the sub-scales for choice among doctors and the
cover for medical expenses did not discriminate between
patients in terms of health status and problems of com-
munication in announcing the diagnosis.
Discussion
These first results have shown that the questionnaire
REPERES-60 presents very satisfactory psychometric prop-
erties. The predominant role given to patients via the
focus groups, a procedure often neglected in the early
stages of instrument design [6,42], made it possible to
explore and develop to the full the content validity of the
21 new items, using dimensions in line with breast cancer
patient expectations [10,18,43].
The focus groups demonstrated that the CSS constituted a
sound base for the development of complementary
dimensions, and also made it possible to reduce the time
required to reach a finalised, validated version [5,40]. The
CSS presented the required psychometric properties [18],
had already been validated in the general population in
France [23] and was designed to assess patient opinion
with respect to care received, technical competence,
human qualities and results. The study of the CSS-VF on a
cohort of women with breast cancer made it possible to
identify a factorial structure that was strictly similar to that
observed in the general population, and thus to validate
its metric qualities in a population of cancer patients [18].
The break-down of items relating to each type of medical
professional involved in cancer treatment was tested
within the CSS-VF. The analysis showed that it was not
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useful to maintain the distinctions, since the redundancy
of the information derived suggested that these items
would encumber the instrument for no good reason, and
in any case these patients do not all have contact with all
the types of professionals that were initially cited. The
strong correlations between items can be explained by the
way in which cancer is cared for in the French healthcare
system. This care is classically provided in one or several
health facilities, but with collegiate decisions among the
specialists concerned (surgeons and oncologists). A
patient when interviewed appears to recall global aspects
of care (there is therefore a correlation among specialist
scores) rather than aspects concerning each specialist. This
tendency is today even more marked in the French "cancer
plan" which seeks to develop this collaboration by pro-
posing the establishment of cancer coordination centres.
However, the distinction between primary care profes-
sionals (GPs and gynaecologists) and secondary care pro-
fessionals (surgeons and oncologists) was maintained in
the questionnaire [21], as in the initial CSS-VF structure,
and enables assessment of the accessibility of the care
institution and the continuity of care in ambulatory treat-
ment [42], and issues such as the importance of the infor-
mal role of GP in breast cancer follow-up [44].
While the CSS-VF can be used its own, the four new
dimensions are complementary to this measure and can-
not be evaluated independently. The new measure covers
aspects of care that have not been widely dealt with in the
literature: continuity of care, solving psychosocial prob-
lems [45], or cooperation between oncologists and GP
[46]. The information that patients are provided with, and
the doctor-patient relationship are areas to which these
patients are particularly sensitive. The 21 items integrates
the information given on the disease, as well as informa-
tion on pain management and breast reconstruction sur-
gery. Some items relate specifically to the types of care
received by the patient (reconstruction, time-lapse before
receiving chemotherapy, radiotherapy and/or surgery).
While care was taken to ensure the internal consistency of
the new items, the choice was made to maintain certain
items that provide information on specific patient treat-
ment that is not otherwise much explored in measures of
satisfaction in cancer. "Not applicable" boxes were added
to these items to identify patients who were not concerned
by the item content.
As expected, lower correlations were observed between
the new scales and QLQ-C30 scales, suggesting that con-
ceptually different issues are assessed [21]. If the correla-
tions observed between the two concepts had proved to
be high, the results would have been in favour of proxim-
ity, rather than independence, between the two tools. The
new scales were able to discriminate clearly between
patients who differed in terms of health status and com-
munication experiences, and to a lesser degree between
patient groups formed on the basis of age and educational
status [38-40].
The comparison between the REPERES-60 questionnaire
and the main satisfaction questionnaires in the field of
cancer was interesting. The literature mainly reports on
instruments developed in hospital environments, the
most commonly used today being the EORTC IN-
PATSAT32 questionnaire. In a hospital environment, the
staffs involved are solely on the one hand cancer special-
ists and on the other the hospital healthcare staff. In a
complete care itinerary, all the doctors encountered over
the itinerary are involved. This explains why: 1) the enu-
meration of staff involved in the two questionnaires dif-
fers: doctors and nurses as opposed to all the doctors over
the full itinerary (primary and secondary care); 2) if the
majority of the dimensions explored by the REPERES-60
questionnaire are also found in the IN-PATSAT32 (inter-
personal skills, technical skills, information provision,
availability, access, exchange of information, comfort,
global satisfaction) psychological support, mentioned by
the patients as necessary for the announcement of the
diagnosis and on leaving the medical environment, is not
explored in the IN-PATSAT32.
Conclusion
Results are convincing but required also further tests such
as the responsiveness and the evaluation of its robustness
in other settings. It is important in generalizing present
results to other linguistic, cultural and healthcare settings
[20]. The task now is to analyse the determinants of
patient satisfaction in relation to their care itinerary and
their clinical characteristics. Identifying the particular
needs of breast cancer patients, and pinpointing the
aspects of care that are the most important to them,
should make it possible to improve the way the disease is
catered for, and provide clinicians with indications on the
way in which their practice is perceived. In this context,
the questionnaire should make it possible, over the com-
plete care itinerary of breast cancer patients, to identify the
points where improvements can be implemented and
integrated into the organisation of care in cancer. The
extension of the questionnaire to other cancers could be
envisaged via the implementation of focus groups involv-
ing patients with the relevant pathology.
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